56 Days
Source:
مباشر
Abuout Raises Annual Profit Forecasts Following Strong Second Quarter Performance
Abbott Labs has raised its revenue outlook for 2026 after delivering strong second-quarter results, surpassing estimates. Sales of medical devices and diabetic care products, especially glucose sensing devices, increased despite a slight dip in nutrition unit sales. The Diagnostics division saw a 13.3% rise in sales, driven by the use of Cologuard in colorectal cancer screening. The company also announced an investigation into a cybersecurity incident within the Diagnostics division, emphasizing that the incident did not impact its operations or financial results.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)